AWP class action proceeds
AWP proposed class action will proceed against all defendants except Roche under a Boston federal judge's ruling. Judge Patti Saris declined to dismiss plaintiffs' claims that drug manufacturers and pharmacy benefit managers - who are not defendants in the case - engaged in racketeering with the objective of promoting fraudulent AWPs, and that manufacturers in the Together Rx discount drug card program engaged in a price-fixing conspiracy. The Together Rx allegations were included in an amended class action complaint in July (1"The Pink Sheet" Aug. 18, 2003, p. 11)...
You may also be interested in...
A class action suit alleges manufacturers participating in the Together Rx discount drug card program are involved in a conspiracy to increase the average wholesale price "spread" on products in the program
A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.
Approval of Alaway Preservative Free (ketotifen fumarate, 0.035) comes 15 months after FDA submitted a complete response letter to Bausch and the active ingredient developer, Eton Pharmaceuticals.